p63 is a transcription factor required for normal epidermal development and differentiation. Because of the complexity of these processes, p63 is expected to regulate a myriad of target genes, providing impetus to many laboratories to identify these genes. p63 target genes have been shown to encode a diverse group of proteins, including structural proteins, proteins that control cell cycle withdrawal, and proteins that regulate the epidermal differentiation program. In this issue, Antonini et al. describe a novel p63 target gene whose evolutionary conservation suggests a critical role for this gene in the epidermis. Dermatology (2008), 128, 1617-1619. doi:10.1038/jid.2008.149 Epidermal morphogenesis begins during embryonic development when cells of the single-layered surface ectoderm, which initially covers the developing embryo, adopt an epidermal fate and differentiate into actively proliferating basal keratinocytes (reviewed in Koster and Roop, 2007). The first morphological sign of stratification occurs when these basal keratinocytes give rise to a suprabasal cell layer. Cells in this so-called intermediate layer undergo a few rounds of cell division before they permanently withdraw from the cell cycle and become spinous keratinocytes. During subsequent stages of epidermal morphogenesis, spinous keratinocytes differentiate into cells of the granular and cornified cell layers, the latter of which are primarily responsible for the barrier function of the epidermis. The end point of the terminal keratinocyte differentiation program is the shedding of the dead and enucleated keratinocytes of the cornified cell layers into the environment. The embryonic differentiation program described above is maintained, with few modifications, during postnatal development. This program is essential to the continuous replacement of cells that are lost and to the maintenance of epidermal tissue architecture.
Epidermal morphogenesis begins during embryonic development when cells of the single-layered surface ectoderm, which initially covers the developing embryo, adopt an epidermal fate and differentiate into actively proliferating basal keratinocytes (reviewed in Koster and Roop, 2007) . The first morphological sign of stratification occurs when these basal keratinocytes give rise to a suprabasal cell layer. Cells in this so-called intermediate layer undergo a few rounds of cell division before they permanently withdraw from the cell cycle and become spinous keratinocytes. During subsequent stages of epidermal morphogenesis, spinous keratinocytes differentiate into cells of the granular and cornified cell layers, the latter of which are primarily responsible for the barrier function of the epidermis. The end point of the terminal keratinocyte differentiation program is the shedding of the dead and enucleated keratinocytes of the cornified cell layers into the environment. The embryonic differentiation program described above is maintained, with few modifications, during postnatal development. This program is essential to the continuous replacement of cells that are lost and to the maintenance of epidermal tissue architecture.
One striking difference between the terminal differentiation programs executed during embryogenesis and those executed postnatally is the mechanism by which the spinous layer is formed. Whereas this layer develops from intermediate keratinocytes during embryonic skin development, basal keratinocytes directly differentiate into spinous keratinocytes in postnatal epidermis. In addition to generating the epidermis, basal keratinocytes also produce and secrete crucial components of the basement membrane, the dermal-epidermal interface, which anchors epidermal keratinocytes to the dermis. Finally, basal keratinocytes participate in epithelial-mesenchymal interactions that are required for the formation of epithelial appendages, including teeth, hair follicles, mammary glands, and limbs.
A key role for the transcription factor p63 in the above-described processes was first inferred from the phenotype of p63-deficient mice. These mice do not develop stratified epithelia or epithelial appendages Mills et al., 1999) . Instead of an epidermis, these mice are covered with a single-layered epithelium that resembles the surface ectoderm that covers the early embryo, suggesting that loss of p63 leads to obstruction of keratinocyte commitment and differentiation and thus to aborted skin development. As a consequence, p63-deficient mice die shortly after birth owing to uncontrolled water loss caused by a lack of skin barrier function.
The p63 gene encodes six different proteins, each of which can function as a transcriptional activator or transcriptional repressor. Because p63-deficient mice lack expression of all six proteins, it is not possible to determine the isoform(s) required for normal skin and appendage development using this animal model. In late embryonic and postnatal epidermis, ∆Np63α is the predominantly expressed p63 isoform, whereas expression of the other isoforms is barely detectable (Yang et al., 1998) . To determine the contribution of ∆Np63α to epidermal development and differentiation, two different groups downregulated ∆Np63 expression in the epidermis using different approaches. We used an epidermalspecific promoter to generate transgenic mice that inducibly express a hairpin sequence consisting of sequences unique to the ∆Np63 isoforms. The hairpin was designed to be processed into short interfering RNA (siRNA) sequences that subsequently degrade endogenous ∆Np63 transcripts (Koster et al., 2007) . Truong and colleagues (2006) took an in vitro approach by downregulating ∆Np63 expression in human primary keratinocytes using an siRNA specific for ∆Np63. These keratinocytes were then placed into organotypic cultures to allow them to regenerate epidermis. In both the transgenic mouse epidermis and the human skin equivalents, the spinous layer failed to develop properly, as demonstrated by a delay in the expression of a marker of the spinous layer, keratin 1 (K1). As a consequence, subsequent stages of terminal differentiation failed to proceed normally. The data summarized above clearly highlight the importance of ∆Np63α in epidermal differentiation.
How does ∆Np63α regulate epidermal development and differentiation? One approach to obtaining insight into the p63 regulatory network is to identify genes whose expression is controlled by p63. Although several groups have performed microarray or chromatin immunoprecipitation (ChIP)-on-chip experiments to address this question, the use of cell lines rather than primary cultures or tissue extracts to perform these high-throughput experiments has limited their biological significance. Nevertheless, several downstream effectors of ∆Np63α have been identified.
Most recently, Antonini and colleagues identified a novel target gene of ∆Np63 that they have named Tprg (transformation-related protein 63 regulated) (Figure 1 ). Unlike ∆Np63α, Tprg is predominantly expressed in the suprabasal layers of the epidermis. Although the role of Tprg in epidermal development and differentiation remains unknown, the expression pattern of Tprg suggests a role for this gene in epidermal differentiation. In further support of this hypothesis, Tprg transcripts are first detected at the developmental stage when terminal differentiation of the epidermis initiates. Although a role for Tprg in epidermal terminal differentiation appears plausible, neither the structure nor the subcellular localization of Tprg provides any clear hints of its precise function. The extensive variety of processes that must occur during terminal differentiation leaves the possibilities open. For example, Tprg may be involved in cell cycle withdrawal, the regulation of structural proteins, and/or barrier formation. Finally, the evolutionary conservation of Tprg suggests a critical role for this protein in the epidermis. However, future experimental approaches, such as the germline deletion of Tprg, will be required to reveal its exact function.
In addition to Tprg, ∆Np63α also regulates the expression of other genes involved in epidermal terminal differentiation. One of these genes is Ikkα, which is a direct transcriptional target of ∆Np63α in the developing epidermis (Koster et al., 2007) (Figure 1 ). The importance of IKKα in epidermal morphogenesis is highlighted by the phenotype of mice lacking IKKα. In IKKα-deficient mice, the intermediate cell layer forms normally. However, in the absence of IKKα, intermediate keratinocytes fail to withdraw from the cell cycle and the spinous layer therefore fails to develop. The consequent failure of the granular and cornified cell layers to develop results in compromised barrier function and early postnatal lethality. In addition to the defects in epidermal morphogenesis, development of epithelial appendages, including teeth and limbs, is aborted in IKKα-deficient mice. These defects are a direct consequence of the failure of the underdeveloped epidermis to participate in the epithelial-mesenchymal interactions required for appendage development (Sil et al., 2004) . Whereas IKKα is primarily responsible for cell cycle withdrawal during keratinocyte terminal differentiation, ∆Np63α also induces markers of terminal differentiation, such as K1. For example, ∆Np63α was found to synergize with Notch signaling components to initiate K1 expression (Nguyen et al., 2006) .
In addition to the induction of genes that are required for epidermal differentiation, ∆Np63α directly induces the expression of genes required for maintaining the structural integrity of the skin. This includes Fras1, a basement membrane component, and Perp, a desmosomal component that is important for cell-cell adhesion (Ihrie et al., 2005; Koster et al., 2007) (Figure 1) . Thus, it comes as no surprise that mice with reduced ∆Np63 expression in the epidermis develop fragile skin that is easily injured, resulting in large skin erosions (Koster et al., 2007) .
Together, the data summarized above establish an emerging network of signaling pathways controlled by ∆Np63α. Due to the complexity of the p63 signaling network, highthroughput approaches may prove to be less useful in identifying components of the pathway that are active only at a certain stage of epidermal development or differentiation. That said, ongoing efforts to identify novel ∆Np63α target genes are needed to further clarify the various complex roles of this intriguing transcription factor in the epidermis. Figure 1 . ∆Np63α regulates the expression of a myriad of target genes. These target genes encode proteins that have different functions in the epidermis. For example, within the basal layer, ∆Np63α induces expression of Fras1, a critical component of the basement membrane. Another structural protein induced by ∆Np63α is Perp, a desmosomal protein that is essential for keratinocyte adhesion. In addition to structural proteins, ∆Np63α induces the expression of IKKα, a protein that is required for cell cycle withdrawal during spinous layer development. Finally, a novel ∆Np63α target gene, Tprg, is expressed in the suprabasal layers of the epidermis and may have a role in epidermal terminal differentiation. 
TAp63 isoforms

INTRODUCTION
A number of transcription factors are known to regulate skin development and differentiation. Among these, p63 is a key modulator of these processes, as is clearly demonstrated in vivo by knockout studies. p63À/À mice fail to form a stratified epidermis, resulting in lack of barrier formation, consequent dehydration, and death within hours after birth (Mills et al., 1999; Yang et al., 1999) . p63 belongs to the p53 gene family consisting of three genes, p53, p63, and p73, that share a significant sequence homology (reviewed by Yang et al., 2002) . Each p53 family member contains a transactivation domain at the amino terminus, a DNA-binding domain, and an oligomerization domain. In addition, all family members share some common functions, and bind to a canonical p53-binding site, thus controlling the expression of a subset of p53 target genes (Yang et al., , 2006 . The use of alternative promoters and transcription start sites gives rise to two classes of p63 transcripts, those encoding proteins with an amino-terminal transactivation domain (TA isoforms) and those encoding proteins lacking this domain (DN isoforms) (Yang et al., 1998) . Three different carboxyl-termini, designated a, b, and g, are generated by alternative splicing. The carboxylterminus of p63-a is the longest and contains a sterile a-motif domain and a transactivation-inhibitory domain (Chi et al., 1999; Thanos and Bowie, 1999; Serber et al., 2002) . Accordingly, DNp63-a has been shown to act as a repressor and to display dominant-negative function against both TAp63 isoforms and p53 (Yang et al., 1998; Ghioni et al., 2002; Westfall et al., 2003; Chan et al., 2004) . However, DNp63-a also positively regulates the expression of some target genes, such as integrins and other adhesion-associated genes (Kurata et al., 2004; Carroll et al., 2006; Truong et al., 2006) , as well as keratin 14 (K14) (Romano et al., 2006) . p63 is predominantly expressed in the basal and spinous layers of the epidermis, and is downregulated upon keratinocyte differentiation both in vitro and in vivo (Parsa et al., 1999; Yang et al., 1999; Liefer et Abbreviations: aa, amino acids; ChIP, chromatin immunoprecipitation; GFP, green-fluorescent protein; hrs, hours; PBS, phosphate-buffered saline; RT-PCR, reverse transcriptase-polymerase chain reaction; siRNA, short interfering RNA; TK, thymidine kinase; Tprg, Transformation-related protein 63 regulated; Tprgl, Transformation-related protein 63 regulated like involved in maintaining cell proliferation and cell adhesion (Koster et al., 2004; Deyoung et al., 2006; Sbisa et al., 2006; Truong et al., 2006) .
As keratinocytes detach from the basement membrane, they begin a program of terminal differentiation, characterized by a change in keratin expression from K5/K14 to a suprabasal pair in the spinous layer (K1/K10). Further keratinocyte differentiation leads to the expression of filaggrin, loricrin, and other cornified envelope components in the granular layer, contributing to the formation of the cutaneous barrier (reviewed by Fuchs, 1998) . It has been proposed that p63 plays a dual role in keratinocyte differentiation, as it is required for initiating epithelial stratification (Koster et al., 2004; Nguyen et al., 2006; Truong et al., 2006) , whereas concurrently it inhibits the expression of some differentiation markers, at least in part through transcriptional repression of the Notch effector Hes1 (King et al., 2003; Nguyen et al., 2006) . Interestingly, some p63 direct targets, such as Perp, whose expression in skin requires p63, are predominantly localized in the suprabasal layers (Ihrie et al., 2005) .
Here, we identify Transformation-related protein 63 regulated (Tprg), a previously uncharacterized gene located upstream of the genomic locus of p63, whose expression is regulated by p63. Tprg encodes for a cytoplasmic protein with a high degree of homology with the gene product of Transformation related protein 63 regulated like (Tprgl), located upstream of the p73 gene. Both loci are conserved throughout vertebrate evolution upstream of p63 and p73, respectively. Tprg is significantly expressed from embryonic day 15.5 in a cell type-specific manner in the epidermis and in the hair follicle in contrast to the ubiquitous expression of Tprgl. We show that Tprg expression is suppressed by p63 knockdown in mouse primary keratinocytes, and is specifically affected by knockdown of the DNp63-a isoform. Interestingly, DNp63-a overexpression also negatively regulates Tprg, suggesting that a finely tuned p63 activity is required for optimal Tprg expression. p63, moreover, directly binds and activates a long-distance enhancer located in a Tprg intronic region. Taken together, our data indicate that Tprg is a previously uncharacterized gene, conserved throughout evolution in proximity of p63, and whose expression is under direct control of p63.
RESULTS
In vertebrates, p63 and p73 proteins are more closely related to one another than to p53, owing to a higher percentage of similarity in the DNA-binding domain as well as the presence of the sterile a-motif domain, absent in p53 (Saccone et al., 2002; Yang et al., 2002) . As p63 and p73 are known to have derived from a gene duplication event, we investigated whether they are embedded in paralogous regions, which would indicate duplication of nearby genes. Interestingly, an uncharacterized gene located 260 kb upstream of the p63 gene in mouse, indicated by the full-length cDNA 5430420C16Rik, is highly homologous to another uncharacterized gene located 101 kb upstream of the p73 gene, indicated by the full-length cDNA 1200015A19Rik (Kawai et al., 2001 ; Figure 1a ). On the basis of the results described below, we have named the above two transcripts Tprg and Tprgl, respectively. They are both transcribed in the same direction as the corresponding p63 and p73 genes, and share 44.1% of identity at the protein level (Figure 1b ). p63 and p73 share a comparable percentage of identity (56.6%), suggesting that they have evolved in a parallel manner, and may be embedded in a paralogue region originated from a single duplication event.
Tprg is transcribed in a 1,087-bp transcript originally isolated as a full-length cDNA from 6 days neonate head and adult female vagina cDNA library (Kawai et al., 2001) . Tprgl is transcribed in a 1,756-bp transcript originally isolated from a cDNA library of adult male lung (Kawai et al., 2001) . To characterize the expression pattern of the two genes, we measured their expression in mouse adult tissues by real time reverse transcriptase-polymerase chain reaction (RT-PCR). Tprg was specifically expressed in skin, and to a much lesser extent in tongue and esophagus (Figure 2a ). In contrast, Tprgl was abundantly expressed in all tested tissues ( Figure 2b ). As previously reported (Yang et al., 1998; Nakamuta and Kobayashi, 2003; Cam et al., 2006) , p63 was expressed at high levels in skin, tongue, muscles, and testis, and to a lesser extent in esophagus and heart (Figure 2c ). DNp63 was the predominant isoform in skin, tongue, and esophagus, whereas TAp63 was highly expressed in muscle and testis (Figure 2d ). Thus, Tprg expression correlates with DNp63 expression in adult mouse tissues. The Tprg gene is predicted to encode for a putative protein of 279 amino acids (aa), whereas the Tprgl gene is predicted to encode for a putative protein of 266 aa. Both proteins have clear orthologues in 26 annotated vertebrate genomes, including other mammals, xenopus, chicken, zebrafish, and fugu (Figure 1c ), but no homology in non vertebrate genomes, indicating them as clearly vertebrate-specific proteins. The putative Tprg and Tprgl proteins share two highly conserved domains, one in the central region (78% of identity in 32 aa) and the other at the carboxyl-terminus of the protein (76% of identity in 29 aa). No known protein domains were found in their sequences. The central portion of the sequence shares a significant degree of similarity with members of the Sac family of phosphoinositide phosphatases in Drosophila melanogaster ( Figure S1) ; however, the similarity occurs within uncharacterized protein domains. Moreover, mouse orthologues of these Drosophila genes exist and they do not display any similarity to Tprg and Tprgl. In the absence of specific antibodies, Tprg protein expression was evaluated by transient transfection of a FLAG-tagged construct. Immunoblotting analysis revealed that FLAG-Tprg protein run at an apparent molecular weight of approximately 36 kDa, consistent with the theoretical molecular weight of the wild-type protein (31 kDa) (Figure 3a) . In mouse primary keratinocytes, immunofluorescence with anti-FLAG antibodies revealed that exogenous Tprg protein was localized in the cytoplasm, whereas being absent from the nucleus (Figure 3b) (Thompson et al., 1994) , showing a high level of conservation among several vertebrate sequences. Similar or identical aa are highlighted in gray. Identical aa are indicated by ''*''; similar aa conserved in all sequences by '':''; and similar aa not conserved in all sequences by ''.''. Underlined are the two regions with highest degree of identity. a structural envelope component, or to participate in the desmosome or other cell junction formations, as the overexpressed protein remains soluble in the cytoplasm even upon Ca 2 þ induced differentiation. Because of its specific expression in skin and its overlap with p63 expression, we investigated Tprg expression in further details. During embryonic development, expression of p63 and basal layer K5 and K14 begins early around embryonic days 8.5-9.5, whereas suprabasal markers start to be expressed at embryonic day 15.5 (Byrne et al., 1994; Koster et al., 2004) . Real-time RT-PCR and in situ hybridization analysis revealed that Tprg was undetectable until embryonic day 15.5 ( Figure 4a , and data not shown). Tprg expression was detected at embryonic day 17.5 in the epidermis and in the developing hair follicle (Figure 4b ). Stronger expression was obtained in skin 4 days after birth (P4) when Tprg was specifically expressed in the epithelial component of the skin, and it was most prominent in the differentiated layers of the epidermis (Figure 4b) . A similar pattern of expression was observed in adult mouse skin, whereas in human skin expression was more broadly distributed ( Figure S2) .
Consistent with the pattern of expression in skin, Tprg mRNA was expressed in both human and mouse primary keratinocytes (Figure 4c , and data not shown). Using mouse primary keratinocytes as a model system, we measured the expression levels of p63, Tprg, K1, and filaggrin under basal undifferentiated conditions (0), and at different time points upon Ca 2 þ -induced differentiation. p63 expression was reduced by Ca 2 þ addition, whereas K1 and filaggrin were induced. K1, however, returned to basal levels by 24 hours (Figure 4c) , consistent with its expression in the spinous layer but not in the granular layer. In contrast, Tprg was expressed under basal conditions and was progressively upregulated upon Ca 2 þ -induced differentiation (Figure 4c ). Forty-eight hours after transfection, immunofluorescence analysis was performed using an anti-FLAG-specific antibody (Tprg, upper panel). GFP staining was used to mark transfected cells (GFP, lower panel). FLAG-Tprg localizes selectively to the cytoplasm, whereas GFP is present both in the nucleus and cytoplasm. Bar ¼ 20 mm.
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Given that Tprg and p63 are predominantly expressed in skin, and their temporal patterns of expression in skin, we asked whether p63 might control Tprg transcription. To test this possibility, we measured the expression of Tprg in p63-knockdown keratinocytes, using previously characterized total p63-specific short interfering RNA (siRNA) . Forty-eight hours after transfection of p63 siRNA in mouse primary keratinocytes, a strong reduction of Tprg expression was observed (Figure 5a ). In contrast, all the other tested genes spanning a genomic region À1.7 Mb þ 687 kb from the p63 gene ( Figure 1a) were not affected by p63 knockdown (Figure 5a ). Similar results were obtained with a previously characterized independent p63 siRNA oligonucleotide (data not shown) . We then asked which specific p63 isoform controls Tprg expression by transfection of isoform-specific siRNA oligonucleotides.
Knockdown of the DNp63 or the a-isoforms strongly inhibited Tprg expression, whereas knockdown of the TA and g-isoforms was unable to affect Tprg, both under basal conditions and upon Ca 2 þ induced differentiation (Figure 5b ; Figure S3 ). Thus, DNp63-a is required for proper expression of the Tprg gene in mouse primary keratinocytes.
To further investigate the regulation of Tprg expression by DNp63-a, we infected primary keratinocytes with a retrovirus expressing DNp63-a protein fused to an estrogen-receptor domain (ERp63) and maintained under basal conditions in an inactive form (Nguyen et al., 2006) . Total RNA was prepared at early time points after ERp63 activation by tamoxifen treatment, and Tprg expression was measured by real-time RT-PCR. Upon DNp63-a activation, Tprg expression was significantly reduced by ERp63 between 40 minutes and 1 hour, suggesting that Tprg is likely to be directly regulated by p63 (Figure 5c ). Interestingly, DNp63-a activation resulted in Tprg downregulation rather than induction. DNp63-a activation is unlikely to repress Tprg due to a generic squelching effect, in agreement with a global gene expression analysis, which revealed that most genes that are repressed by p63 activation are induced by p63 knockdown (Giusy Della Gatta and Caterina Missero, in preparation). A similar inhibition of Tprg expression was observed in primary keratinocytes infected with an adenovirus expressing DNp63-a (Figure 5d ), suggesting that Tprg expression is finely regulated by DNp63-a in keratinocytes. Regulation of Tprg expression by p63 could either occur directly through p63 binding to a Tprg-regulatory sequence or could be mediated by other mechanisms. To identify potential p63-binding sites in the Tprg gene, we examined the entire genomic region containing the Tprg locus for p63-binding sites, using a recently performed genome-wide chromatin immunoprecipitation (ChIP)-on-chip analysis in human carcinoma cells (Yang et al., 2006) . The Tprg gene spans 151 kb in the human genome and has five introns. Interestingly, two genomic regions located in human Tprg intron 4 displayed p63-binding activity with a significant binding score, whereas no p63 binding could be detected in the Tprg putative proximal promoter or in upstream regions (up to 50 kb from the transcription start site). Both genomic regions identified are conserved throughout evolution ( Figure  6a , and data not shown); however, only one displays a p53/ p63 consensus sequence that is conserved between human and chicken (Figure 6b) . We proceeded to test whether p63 could bind in vivo to the latter. ChIP was performed using anti-p63-specific antibodies in human primary keratinocytes, and amplifying three sequences approximately 500 bp apart (Figure 6a) . Interestingly, p63 specifically bound to the sequence corresponding to the most highly conserved region and containing the conserved p63-binding site (Figure 6c) . A strong binding was obtained with the corresponding mouse sequence in mouse primary keratinocytes, where p63 bound the Tprg-binding site to a similar extent of as that of a highaffinity long-distance enhancer (C40 enhancer; Antonini et al., 2006; Yang et al., 2006; Figure 6d ). This genomic region is likely to contain a functional p63-binding site and also to function as an enhancer. We tested this possibility by cloning the conserved genomic region containing the binding site upstream of a thymidine kinase (TK) minimal promoter driving the expression of a luciferase gene. Transient transfection assays in HeLa cells revealed that the Tprg enhancer activity was positively regulated by p63 in a dosedependent manner (Figure 6e ). Thus, p63 controls Tprg gene expression by directly binding to a previously unreported highly conserved long distance enhancer located at approximately 100 kb from the putative Tprg transcription start site.
DISCUSSION
Tprg was identified here as a previously uncharacterized gene physically located upstream of the p63 gene in the vertebrate genomes, whose expression is regulated by p63. Tprg encodes for a protein highly homologous to the one encoded by the Tprgl gene, located upstream of the p73 gene. A Tprg/Tprgl ancestor gene is absent in invertebrates, including in the invertebrate chordate Ciona intestinalis (Dario Antonini and Caterina Missero, unpublished observations). Given the similar percentage of identity at the protein level between Tprg/Tprgl and p63/p73, and the absence of genes homologous to Tprg in non-vertebrate genomes, we propose that Tprg and Tprgl emerged during invertebrate-tovertebrate transition of the p53 family, arising from the segmental duplication of the p63/p73 locus in vertebrates.
The proteins encoded by Tprg and Tprgl are highly conserved throughout the vertebrate lineage, with long stretches of aa showing very high conservation across both Tprg and Tprgl from fish to human. Surprisingly, however, these proteins do not contain any known protein domains. Even the most conserved stretches of amino-acid sequence (the DHWNNE ''signature'' around amino acid 110 and the KYDF stretch at amino acid 130) are not explained by any specific protein feature. Some similarity is observed with some phosphoinositide phosphatases, and it would be tempting to speculate a connection between the role of these proteins in Ca 2 þ mobilization from intracellular stores, or intracellular trafficking. The conservation, however, is poor, and lies outside of any known protein domains. Moreover the similarity to this family of proteins is more significant in lower organisms such as Drosophila and Aspergillus, despite the fact that these proteins do exist in mammalian genomes. Thus, this significance of this similarity will require further investigation.
We demonstrate here that p63 is required for Tprg expression in skin, and that p63 exerts a direct control by binding in human as well as in mouse to a genomic region in Tprg intron 4, which acts as a p63-dependent enhancer. Genome-wide analysis of p63-binding regions by ChIP-onchip demonstrated that on average p63-binding sites are Conserv Mouse Rat Dog Chicken Figure 6 . p63 binds to a highly conserved Tprg intronic region. (a) A 2-kb genomic region located in intron 4 and previously found to bind p63 by ChIP-on-chip (Yang et al., 2006) is shown (horizontal black bar). Three sequences were selected for amplification to test p63-binding in human and mouse primary keratinocytes (Tested seq 1-3). The degree of evolutionary conservation is represented by vertical black bars and peaks. (b) A conserved p63-binding site is located within region 2. The predicted p63-binding site is indicated together with its precise nucleotide sequence: bold nucleotides correspond to the core nucleotide sequence required for p63-binding (el-Deiry et al., 1992; Barbieri et al., 2005; Ihrie et al., 2005; Antonini et al., 2006; Nguyen et al., 2006; Yang et al., 2006) , while underlined nucleotides are matches in the consensus. Nucleotides identical in all species are indicated by *. (c) Specific binding of endogenous p63 to the human Tprg regions. Human primary keratinocytes under growing conditions were processed for ChIP with antibodies specific for p63 ( þ ), or unrelated anti-ERK1 antibodies as control (À), followed by real-time PCR amplification of various regions of the Tprg intronic sequences indicated in the schematic above. Unprecipitated chromatin preparations were similarly analyzed and used as ''input'' control. The amount of precipitated DNA was calculated relative to the total input chromatin, and expressed as the percentage of the total (Frank et al., 2001) . (d) Specific binding of endogenous p63 to the mouse Tprg region corresponding to the human conserved binding site (Tprg) and to the previously characterized C40 enhancer used as control . ChIP was performed as described in (c). (e) The Tprg enhancer is responsive to p63. The Tprg putative enhancer region was cloned in front of a TK minimal promoter that drives the expression of the luciferase reporter. The construct was transiently transfected into HeLa cells in the absence (À) or in the presence of various concentrations of an expression construct for DNp63-g as indicated (in mg). The activity of the enhancer was measured by luciferase assays and values are expressed relative to (À) set to 1.
38.6% nucleotide-identical between human and mouse (Yang et al., 2006) . The p63-binding site in the Tprg intron 4 is conserved in mammals and in chicken, and is more than 90% identical between human and mouse, thus being among the most conserved binding regions identified to date. Interestingly, we identify that p63 binds to several other highly conserved binding sites in the genomic region encompassing Tprg and p63 Yang et al., 2006, and Dario Antonini and Caterina Missero, unpublished data) , and their functional relevance will require further investigation.
Although p63 is required for Tprg expression, Tprg starts to be expressed in embryonic skin much later than p63, and unlike p63, it is more abundant in differentiated keratinocytes, at least in the developing and newborn skin, suggesting either that other transcription factors may be involved in Tprg expression in the suprabasal compartment, or that a balance between different p63 isoforms may trigger Tprg expression. The expression and putative function of the various p63 isoforms in skin is controversial. It has been proposed that during embryogenesis DNp63-a is required to counterbalance the inhibitory effect of TAp63-a on terminal differentiation (Koster et al., 2004) . However, DNp63 isoforms are highly expressed even before epidermal stratification, whereas the TAp63 isoforms are expressed at very low levels (Laurikkala et al., 2006) . Similarly, in normal human and mouse epidermis, DNp63-a is the most abundant p63 splice variant, whereas very weak expression of TAp63-a and DNp63-g is detected at the RNA but not at the protein level (Bamberger et al., 2002 (Bamberger et al., , 2005 . In primary keratinocytes, DNp63-a is readily detectable at the protein level under proliferating conditions, and declines upon Ca 2 þ -induced differentiation. The onset of differentiation in human keratinocytes does not change the ratio of two other very weakly expressed isoforms (Bamberger et al., 2002) . In mouse keratinocytes, it has been reported that the TAp63-g isoform is induced upon Ca 2 þ addition (King et al., 2006) , although under our culture conditions, we could not detect any significant change in TAp63 expression during differentiation (data not shown). Our knockdown studies clearly demonstrate that Tprg expression is dependent on DNp63-a, whereas the TAp63 and p63-g isoforms do not alter Tprg expression under proliferating or differentiating conditions. Consistent with these data, Tprg expression in the adult mouse follows the tissue distribution of DNp63, whereas it is not expressed in tissues where TAp63 is abundant.
In contrast to p63, Tprg expression in skin and in isolated keratinocytes is higher in differentiated keratinocytes than in basal keratinocytes. Accordingly, p63 is required for Tprg expression in keratinocytes (Figure 5a and b) , but high levels of p63 results in Tprg downregulation (Figure 5c and d) , suggesting that optimal Tprg expression may require levels of p63 expression lower than those present in the basal layer. Thus, DNp63-a finely regulates Tprg expression possibly in conjunction with other transcription factors.
In conclusion, we have identified Tprg as a gene, predominantly expressed in skin, likely to be co-regulated with its adjacent gene p63. We have shown that p63 participates directly in the transcriptional control of Tprg expression in skin. Tprg gene and its paralogue Tprgl encode for proteins, which are specific to the vertebrate lineage and highly conserved in sequence; however, their functions will require further investigation.
MATERIALS AND METHODS
Cell cultures, transfections, and reporter assays Mouse primary keratinocytes were isolated from 2-day-old Swiss CD1 mice and cultured under low-Ca 2 þ conditions (0.05 mM) in the presence of 4% Ca 2 þ -chelated fetal bovine serum (Invitrogen, Carlsbad, CA), and epidermal growth factor (Invitrogen), as previously described . Terminal differentiation was induced by addition of 0.2 mM calcium chloride to the medium. Human primary keratinocytes were kindly provided by Dr GP Dotto, and cultured in keratinocyte-serum-free medium medium supplemented with bovine pituitary extracts and epidermal growth factor (Invitrogen). Human embryonic kidney 293 and HeLa cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum. All cell types were transfected using Lipofectamine 2000 (Invitrogen) following the manufacturer's protocol. Confluent mouse primary keratinocytes were transfected 5 days after plating. Keratinocytes in 60-mm dishes were transfected with 2 mg of pCMV2-FLAG-Tprg and pCMV2-FLAG (control) together with 0.2 mg of pCMV-GFP (green-fluorescent protein; Clontech, Palo Alto, CA), or with 200 mM of stealth siRNA for mouse p63-a, -g, DNp63, Tap63, or an siRNA recognizing all isoforms Supplementary Material) , or a control medium GC-rich stealth siRNA (Invitrogen). HeLa cells in 12-well dishes were transfected with a construct carrying the Tprg enhancer and the TK minimal promoter driving the expression of the luciferase gene (see below) (0.25 mg); the DNp63-g (0.05 and 0.1 mg); and CMV-Renilla (0.02 mg; Promega, Madison, WI). Luciferase activity was determined 48 hours after transfection with the dual-luciferase reporter assay kit (Promega). Renilla luciferase activity was used to normalize transfection efficiency.
Plasmids and constructs
For the retrovirus expressing inducible p63, a modified ER ligandbinding domain (Littlewood et al., 1995) was cloned in frame between the FLAG epitope and the DNp63-a cDNA lacking the first ATG, and inserted into the HindIII-NotI sites under the control of the CMV promoter in the PINCO retroviral vector (Nocentini et al., 1997) . The pCMV2-FLAG Tprg expression vector was obtained by amplifying the putative coding sequence of Tprg lacking the ATG from mouse primary keratinocyte cDNA using the PfuI polymerase (Stratagene, La Jolla, CA) with specific oligonucleotide primers (see Supplementary Material), and by cloning it in frame in pCMVFLAG2 (Sigma, St. Louis, MO) in NotI-XbaI. The construct was sequence verified and tested by immunoblotting for its ability to encode for a protein. The Tprg enhancer sequence (597 bp) was amplified by PCR from mouse genomic DNA using specific oligonucleotide primers (see Supplementary Material), and cloned in the pGL3-TK-Luc construct (Ohno et al., 1999) at the KpnI site. The enhancer sequence was verified by sequencing.
Real-time RT-PCR and microarray
Mouse embryos and adult tissues derived from adult CD1 female mice were snap frozen, pulverized, and dissolved in TRIzol reagent www.jidonline.org 1683 D Antonini et al.
(Invitrogen) for RNA preparation according to manufacturer's protocol. RNA samples were treated with RNase-free DNaseI (Promega). cDNA was synthesized using Superscript III (Invitrogen). Two-step real-time RT-PCR was performed using the SYBR Green PCR core kit (Applied Biosystems, Foster City, CA). Expression of the endogenous Tprg transcript, as well as of the other target genes, was quantified using specific oligonucleotide primers (see Supplementary Material).
Immunostaining and immunoblotting
Forty-eight hours after transfection, mouse primary keratinocytes were fixed in methanol for 5 minutes at À20 1C, washed in phosphate-buffered saline (PBS), and permeabilized in 0.2% Triton/PBS. Fixed cells were incubated with anti-FLAG biotinylated antibodies (BioM2, 1:100; Sigma) in 0.1% Triton/5% goat serum/PBS for 1 hour at room temperature. After extensive washing in 0.1% Triton/PBS, cells were incubated with streptavidin Cy3 (1:100; Sigma), washed, and stained with 4',6-diamidino-2-phenylindole at 100 ng ml À1 in PBS. Slides were mounted using Vectashield as mounting reagent (Vector Laboratories, Burlingame, CA), and examined under an Axioplan imaging microscope (Zeiss, Micro Imaging, Thornwood, NY). For immunoblotting, human embryonic kidney 293 cells plated in 60-mm dishes were transfected with 4 mg of pCMV2-FLAG Tprg or empty vector as control. Cells were lysed in sample buffer 24 hours after transfection. Protein extracts (10 mg) were run on 12% SDS-PAGE and transferred on an Immobilon-P transfer membrane (Millipore, Bedford, MA). The membrane was probed with anti-Flag monoclonal antibodies (M5, Sigma), or with anti-extracellular signal-regulated kinase (ERK) antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) as loading control.
In situ hybridization
Skin was fixed in 4% fresh paraformaldehyde overnight at 4 1C, washed in PBS, incubated in 30% sucrose/PBS overnight at 4 1C, and embedded in OCT compound (Sakura, Torrance, CA). In situ hybridization was performed as described previously (Brancaccio et al., 2004) . Hybridization was performed with 1 mg ml À1 of digoxygenin-labeled Tprg cRNA probe corresponding to a cDNA fragment of 511 bp of coding sequence (see Supplementary Material), and cloned into pCR2.1-TOPO vector. Antisense and sense probes were transcribed from the T3 and T7 promoters, respectively, using a digoxygenin labeling kit (Roche, Basel, Switzerland) as described by manufacturer's instructions. Mice were housed and treated according to the guidelines of the local Institutional Animal Care and Use Committee. This study was conducted under approval of the Institutional Review Board and according to the Declaration of Helsinki Principles. Written informed consent was obtained from the human skin donors.
Chromatin immunoprecipitation
Approximately 3 Â 10 6 mouse keratinocytes were fixed with 1% formaldehyde in growth medium at 37 1C for 10 minutes. Extracts were extensively sonicated on ice to obtain DNA fragments ranging from 200 to 800 bp in length. Chromatin was immunoprecipitated following the Upstate protocol (http://www.upstate.com). Immunoprecipitation was performed using anti-p63 (H-137; Santa Cruz Biotechnology) and anti-ERK-1 (K23; Santa Cruz Biotechnology)
antibodies. Real-time PCR was performed using the SYBR Green PCR master mix in an ABI PRISM 7000 (Applied Biosystems), using specific oligonucleotide sequences (see Supplementary Material).
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